NO20052574L - Fremgangsmate til a fremstille en farmasoytisk aktiv forbindelse og til a fremstille dens mellomprodukt - Google Patents

Fremgangsmate til a fremstille en farmasoytisk aktiv forbindelse og til a fremstille dens mellomprodukt

Info

Publication number
NO20052574L
NO20052574L NO20052574A NO20052574A NO20052574L NO 20052574 L NO20052574 L NO 20052574L NO 20052574 A NO20052574 A NO 20052574A NO 20052574 A NO20052574 A NO 20052574A NO 20052574 L NO20052574 L NO 20052574L
Authority
NO
Norway
Prior art keywords
preparing
active compound
pharmaceutically active
dichlorophenyl
formula
Prior art date
Application number
NO20052574A
Other languages
English (en)
Norwegian (no)
Inventor
Pere Dalmases Barjoan
Jordi Bessa Bellmunt
Original Assignee
Vita Cientifica Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Cientifica Srl filed Critical Vita Cientifica Srl
Publication of NO20052574L publication Critical patent/NO20052574L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20052574A 2002-10-31 2005-05-27 Fremgangsmate til a fremstille en farmasoytisk aktiv forbindelse og til a fremstille dens mellomprodukt NO20052574L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200202502A ES2209639B1 (es) 2002-10-31 2002-10-31 Procedimiento para la obtencion de un compuesto farmaceuticamente activo y obtencion de su intermedio.
PCT/IB2003/004763 WO2004039767A1 (en) 2002-10-31 2003-10-27 Process for preparing a pharmaceutically active compound and for preparing its intermediate

Publications (1)

Publication Number Publication Date
NO20052574L true NO20052574L (no) 2005-05-27

Family

ID=32187427

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052574A NO20052574L (no) 2002-10-31 2005-05-27 Fremgangsmate til a fremstille en farmasoytisk aktiv forbindelse og til a fremstille dens mellomprodukt

Country Status (8)

Country Link
US (1) US7179913B2 (es)
EP (1) EP1556341A1 (es)
KR (1) KR100753354B1 (es)
AU (1) AU2003272019A1 (es)
ES (1) ES2209639B1 (es)
IS (1) IS7846A (es)
NO (1) NO20052574L (es)
WO (1) WO2004039767A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007069265A1 (en) * 2005-12-12 2007-06-21 Unichem Laboratories Limited A novel process for the synthesis of lamotrigine and its intermediate
US20120142919A1 (en) * 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
WO2009069073A1 (en) * 2007-11-28 2009-06-04 Alembic Limited An improved process for the preparation of lamotrigine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059987B1 (en) 1979-06-01 1985-08-14 The Wellcome Foundation Limited Alpha-cyano-alpha-((n-guanidino)-imino) toluenes
GB8613183D0 (en) 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
CA2334937C (en) 1998-12-14 2004-09-21 Torrent Pharmaceuticals Ltd. An improved process for the preparation of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
US6639072B1 (en) * 2000-01-03 2003-10-28 Rpg Life Sciences Limited Process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
IL134730A (en) * 2000-02-25 2003-10-31 Chemagis Ltd Process for preparing substituted benzoyl cyanide amidinohydrazones
CA2366521C (en) * 2001-12-24 2007-03-06 Brantford Chemicals Inc. A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines
HU225667B1 (en) * 2002-09-20 2007-05-29 Richter Gedeon Nyrt Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine

Also Published As

Publication number Publication date
ES2209639B1 (es) 2005-08-01
KR100753354B1 (ko) 2007-08-30
WO2004039767A1 (en) 2004-05-13
US20060052625A1 (en) 2006-03-09
US7179913B2 (en) 2007-02-20
EP1556341A1 (en) 2005-07-27
KR20050083883A (ko) 2005-08-26
IS7846A (is) 2005-05-13
ES2209639A1 (es) 2004-06-16
AU2003272019A1 (en) 2004-05-25

Similar Documents

Publication Publication Date Title
CY1112496T1 (el) Μεθοδος παρασκευης παραγωγων βενζοϊκου οξεος
TWI348371B (es)
MY134666A (en) Pyridinoylpiperidines as 5-ht1f agonists
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
NO20055971L (no) Cyanofluorpyrrolidinderivat
NO20063268L (no) Fremgangsmate til fremstilling av 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-metoksybenzyl)quinuklidin-3-amin
CA2469592A1 (en) Hiv integrase inhibitors
WO2004012663A3 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
NO20052574L (no) Fremgangsmate til a fremstille en farmasoytisk aktiv forbindelse og til a fremstille dens mellomprodukt
MXPA04006041A (es) Antivirales de piridoquinoxalina.
NO20076000L (no) Aminosyrederivater
IS5497A (is) Bífenýlamidínafleiður
WO2002028855A3 (en) Amorphous form of cell cycle inhibitor
PT1474426E (pt) Processo para o fabrico de compostos de carbapenema
Miyazaki et al. Synthesis and evaluation of pyrrolin-2-one compounds, a series of plasminogen activator inhibitor-1 inhibitors
WO2007000392A3 (en) Chloro-substituted guanidines
WO2006107478A3 (en) Crystalline sodium salt of an hiv integrase inhibitor
ES2224074T3 (es) Procedimiento para la preparacion de lamotrigina a partir de alfa-oxo-2,3-diclorofenilacetilamidino-aminoguanidino-hidrazona mediante reaccion del cierre de anillo.
ZA200402321B (en) Pharmaceutically acceptable salts of 20(S)-camptothecins.
MXPA04003478A (es) Sintesis de (4-bromofenil)(4-piperidil)metanona-(z)-o-etiloxima y sales.
TH64452A (th) อนุพันธ์ของฮาโลจีเนเตต 2-อะมิโน-5,6-เฮปทีโนอิก แอซิดที่เป็นประโยชน์ในฐานะตัวยับยั้ง ไนตริก ออกไซด์ ซินเธส

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application